Skip to main content

Research Repository

Advanced Search

The patient with abnormal cervical cytology

Underwood, M.; Parry-Smith, W.R.

Authors

M. Underwood



Abstract

This chapter includes clinical cases, background, evidence-based practical management options, preventive measures, key-point summaries of abnormal cervical cytology and answers to questions patients ask. Cervical screening programs around the world vary significantly, with vast differences in frequency and age of commencement of screening programs, if screening programs exist at all. The aim of all cervical screening programs is to detect precancerous lesions early to avoid the progression to cervical cancer. Good practice would be to ensure all patients referred to fertility clinics are up to date with their local cervical screening program, and if they are not, they should be encouraged to take up this opportunity to have the screening. Glandular abnormalities warrant a prompt direct referral to colposcopy and should be seen within 2 weeks. In health systems without HPV test of cure, cytological follow up at 6 months and then annually for 10 years should be followed.

Citation

Underwood, M., & Parry-Smith, W. (2021). The patient with abnormal cervical cytology. In Assisted Reproduction Techniques: Challenges and Management Options (123-126). Wiley. https://doi.org/10.1002/9781119622215.ch19

Online Publication Date Jun 4, 2021
Publication Date 2021
Deposit Date Apr 17, 2024
Publisher Wiley
Pages 123-126
Book Title Assisted Reproduction Techniques: Challenges and Management Options
Chapter Number 19
ISBN 9781119622215 9781119622109
DOI https://doi.org/10.1002/9781119622215.ch19